Research Updates in Psoriatic Arthritis: American College of Rheumatology Convergence 2020

To participate in this activity, please:

The latest research related to the treatment of patients with psoriatic arthritis is often first made public at the American College of Rheumatology (ACR) annual meeting. In this CME activity, Dr. Roy Fleischmann of the University of Texas Southwestern Medical Center at Dallas discusses three posters presented at ACR Convergence 2020. Dr. Fleischmann first summarizes the methods and results of each of these posters, then provides his own thoughts as to the importance of the research findings and implications for clinical practice in the treatment of patients with psoriatic arthritis.

Course Credit:

0.75 AMA PRA Category 1 CreditTM


Opens: 2020-12-31
Closes: 2021-12-30

Target Audience:

This activity is intended for a national audience of rheumatologists, dermatologists, primary care physicians and other healthcare providers who manage patients with psoriatic arthritis.

This activity is supported by an educational grant from Janssen Biotech, Inc.
  • Roy M. Fleischmann, MD

    Clinical Professor of Medicine
    University of Texas Southwestern Medical Center
    Medical Director
    Metroplex Clinical Research Center
    Dallas, Texas

Learning Objectives

  • Summarize the latest research developments in the treatment of psoriatic arthritis
  • Describe how new data and recommendations can impact clinical practices to improve care
  • Incorporate evidence-based research into clinical practice

Faculty Disclosures

Roy M. Fleischmann, MD

Consultant: AbbVie, Amgen, Eli Lilly, GSK, Pfizer, UCB

Research Support: AbbVie, Amgen, BMS, Eli Lilly, GSK, Pfizer, Sanofi, TEVA, UCB

Accreditation and Certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Content Planners

Eugene Cullen, MD (Peer Reviewer)

No significant relationship to disclose

Gregory Scott, PharmD, RPh (Medical Writer)
No significant relationships to disclose.

Annenberg Center for Health Sciences

All members of the Eisenhower Health Education Committee have no relevant commercial relationships to disclose.